Daniel R. Omstead's Insider Trades & SAST Disclosures
Daniel R. Omstead's most recent trade in Tekla Life Sciences Investors was a trade of 10,096 Shares of Beneficial Interest done at an average price of $12.4 . Disclosure was reported to the exchange on Sept. 25, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Daniel R. Omstead.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tekla Life Sciences Investors | Daniel R. Omstead | Director, President | 25 Sep 2023 | 10,096 | 197,518 (0%) | 0% | 12.4 | 125,116 | Shares of Beneficial Interest | |
| Tekla Healthcare Investors | Daniel R. Omstead | Director, President | Purchase of securities on an exchange or from another person at price $ 15.63 per share. | 25 Sep 2023 | 9,500 | 178,268 (0%) | 0% | 15.6 | 148,515 | Shares of Beneficial Interest |
| Tekla Life Sciences Investors | Daniel R. Omstead | Director, President | 20 Sep 2023 | 12,000 | 187,422 (0%) | 0% | 12.7 | 152,206 | Shares of Beneficial Interest | |
| Tekla Healthcare Investors | Daniel R. Omstead | Director, President | Purchase of securities on an exchange or from another person at price $ 15.88 per share. | 20 Sep 2023 | 9,500 | 168,768 (0%) | 0% | 15.9 | 150,829 | Shares of Beneficial Interest |
| Tekla Life Sciences Investors | Daniel R. Omstead | Director, President | 11 Aug 2021 | 6,403 | 146,489 (0%) | 0% | 21.6 | 138,497 | Shares of Beneficial Interest | |
| Tekla World Healthcare Fund | Daniel R. Omstead | Director, President | 06 Apr 2021 | 24,326 | 0 | - | - | Subscription Rights | ||
| Tekla World Healthcare Fund | Daniel R. Omstead | Director, President | 06 Apr 2021 | 6,442 | 30,768 (0%) | 0% | 14.3 | 91,876 | Shares of Beneficial Interest | |
| Tekla Life Sciences Investors | Daniel R. Omstead | Director, President | 21 Oct 2020 | 5,950 | 125,660 (0%) | 0% | 17.7 | 105,606 | Shares of Beneficial Interest | |
| Tekla Healthcare Investors | Daniel R. Omstead | Director, President | Purchase of securities on an exchange or from another person at price $ 20.68 per share. | 21 Oct 2020 | 5,050 | 120,211 (0%) | 0% | 20.7 | 104,427 | Shares of Beneficial Interest |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges